Necessity of routinely performing foraminoplasty during percutaneous endoscopic transforaminal discectomy (PETD) for...

To assess the role of foraminoplasty during percutaneous endoscopic transforaminal discectomy (PETD) and compared the 2-year clinical results of patients underwent PETD w/o foraminoplasty.

A total of 412 patients, who underwent PETD at L3-S1 by the same surgical group, were enrolled in this study. The MRI was used to determine the height (H1) and width (W1) of the intervertebral foramen of L3-S1, the distance between the exiting nerve root and the upper edge of the lower vertebral pedicle (H2), and the distance (W2) between the point with 3 mm to the ventral side of the intervertebral space and superior articular process. The intervertebral foramen widths in the flexion (W3) and extension positions (W4) were also measured. A VAS of low back pain (LBP) and leg pain, ODI and JOA scores of LBP were used to assess the clinical results.

Intraoperative verification showed that 347 cases (group A) did not need foraminoplasty, while the other 65 patients (group B) needed foraminoplasty, including 31 at L4-5 and 34 at L5-S1. The H1 and H2 of L3-S1 were reduced gradually without significant difference between two groups. The W1, W2, W3 and W4 were higher in group A (p < 0.05). The W3 was higher than W4 in both groups (p < 0.05). At 2-year follow-up, there was no significant difference of ODI and JOA score between two groups (p > 0.05). The VAS score of LBP was better in group A (p < 0.05).

Most of PETD procedure at L3-S1 levels could reach the therapeutic target without foraminoplasty. Due to anatomic characteristics of L5-S1, the foraminoplasty rate was much higher at L5-S1.